Background: Smoking cessation can lead to changes in appetite and weight gain in some
INTRODUCTION
Tobacco smoking is associated with a number of gastrointestinal disorders (1, 2) .
Nicotine is the principal active component in tobacco and nicotine exposure is often considered to be synonymous with smoking. The pharmacological effects of nicotine have been elucidated for several gastrointestinal disorders (1, 2) . For peptic ulcers, nicotine stimulates pepsinogen and vasopressin secretion, reduces mucosal blood flow and suppresses mucosal restitution. For gastroesophageal reflux disease (GERD), nicotine decreases lower esophageal sphincter pressure and distal esophageal peristalsis.
The effects of smoking and nicotine on gastric emptying remain controversial. Gritz et al. (3) and Miller et al. (4) reported that smoking delays gastric emptying of solids, particularly during the initial phase, according to scintigraphy. A precise study using dual scintigraphy by Scott et al. (5) also demonstrated that acute smoking produces antrofundal redistribution and delays gastric emptying of solid and liquid meals. However, Wong et al. (6) reported that acute transdermal nicotine administration does not affect gastric emptying of solids and liquids according to gastric scintigraphy. A study by Sanaka et al. using the 13 C-octanic acid breath test (7) demonstrated that acute smoking accelerates gastric emptying in the later phase.
The general consensus is that smoking cessation can lead to some degree of appetite and weight gain. A positive association between gastric emptying and appetite has been suggested (8, 9) . Smoking cessation thus seems likely to alter gastrointestinal motility.
However, the effects of smoking cessation on gastric emptying in smokers have not been established. The present study sought to determine how smoking cessation affects gastric emptying in smokers.
MATERIALS AND METHODS
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Patients
In this study, we defined habitual smokers as current smokers who smoke over 10 packs years (calculated as packs per day × smoking years, or as cigarettes per day × smoking years/20). Subjects comprised 53 habitual smokers (41 men, 12 women; mean age, 46 ± 16 years; range, 20 -74 years), and 18 healthy never-smoker controls (14 men, 4 women; mean age, 46 ± 18 years; range, 24 -75 years). Subjects received no remuneration, but habitual smokers received nicotine patches at no cost.
Habitual smokers were treated for 8 weeks with transdermal nicotine patches (Nicotinell TTS, Novartis Pharma K.K., Tokyo, Japan ). They used 52.5-mg patches for a total of 4 weeks, 35-mg patches for 2 weeks, and 17.5-mg patches for 2 weeks. After treatment was started, patients were not allowed to smoke. We discontinued treatment and excluded subjects from the study if they resumed smoking. Body weight and height were measured, and BMI was calculated in smokers at the beginning of the study, and at 1 and 9 weeks after cessation of the nicotine patch. Ten-centimeter visual-analogue scale data for appetite before breakfast (0 cm refers to the weakest appetite, and 10 cm indicates the greatest appetite) were also obtained from smokers at each point. None of the subjects were being treated with painkillers, antidepressants, hormone drugs or medicines for the stomach or bowels. Patients with diabetes mellitus, endocrine disease, renal failure, pregnancy, severe obesity (body mass index (BMI) > 40 kg/m 2 ), cachexia, alcohol abuse or a past history of gastrointestinal surgery were excluded from this study. Presence of serum immunoglobulin (Ig)G antibody to H. pylori was examined by enzyme immunoassay (SRL, Tokyo, Japan).
The study protocol was approved by the Medical Ethics Committee of Nagasaki University.
Written informed consent was obtained from each subject in accordance with the Helsinki Declaration. Kadota 
Gastric emptying
Gastric emptying was measured using the 13 C acetate breath test at 09:00 following an overnight fast. Briefly, patients ingested a liquid test meal (OKUNOS-A; 200 kcal/200 ml; Forica Foods, Niigata, Japan) labeled with 100 mg of sodium 13 C-acetate (Sodium Acetate (1-13C,99%); Euriso-Top, Saint-Aubin, France). Breath samples for 13 CO 2 measurements were collected in air bags at baseline (before test meal) and at 10-min intervals for 2 h after intake of the test meal. Analysis of isotopic enrichment was performed using an isotope ratio mass spectrometer with an online gas chromatographic purification system (UBiT-IR 200;
Otsuka Pharmaceuticals, Tokyo, Japan). The Gastric emptying was studied at the beginning of the study, and at 1 and 9 weeks after cessation of the nicotine patch.
Statistical analysis
All data are expressed as means ± standard deviation. Differences between groups were examined for statistical significance using Student's t-test and the Wilcoxon signed-ranks test. Values of P < 0.05 denote the presence of a statistically significant difference. All statistical analyses were performed using SPSS v15.0 software (SPSS Japan, Tokyo, Japan).
RESULTS
Delayed rate of gastric emptying in smokers
We initially compared the rate of gastric emptying between smokers and controls.
Demographically, no significant differences were found in smokers and controls with regard to age, gender or presence of H. pylori using the serum antibody test. Mean T max was 0.94 ± 0.3 h for smokers (n = 53) and 0.89 ± 0.1 h for controls (n = 18). T max was reached significantly later in smokers than in controls (P = 0.014, Student's t-test) (Fig. 1) .
T max and T 1/2 decrease temporarily after smoking cessation
All 53 habitual smokers were treated with transdermal nicotine patches. Side effects such as nausea, headache, insomnia and skin reactions were observed during patch use. Most subjects tolerated these side effects, but 1 patient stopped using the nicotine patch due to skin reactions. Of the 53 smokers, 22 smokers succeeded in quitting until 9 weeks after cessation of patch use, whereas 31 smokers failed to quit (9 smokers succeeded in quitting until 1 week after cessation of patch use, but began smoking again, while 22 smokers resumed smoking during patch use). Only data from the 22 subjects who successfully quit smoking was analyzed.
Body weight and BMI increased by a mean of 1.8 ± 2.0 kg and 0.6 ± 0.8 kg/m 2 at 1 week after the end of treatment, and an additional 0.7 ± 1.2 kg and 0.3 ± 0.5 kg/m 2 at 9 weeks after the end of treatment. Appetite measured by visual-analogue scale also increased by a mean of 1.5 ± 2.4 cm at 1 week after the end of treatment and had decreased by 0.1 ± 1.7 cm at 9 weeks after the end of treatment (Table 1) .
Next, we compared the rates of gastric emptying in the 22 successful quitters between the beginning of the study and 1 or 9 weeks after cessation of patch use. At 1 week after the end of treatment, T max decreased significantly from 1.05 ± 0.32 h to 0.72 ± 0.64 h (n = 22, P = 0.003, Wilcoxon signed-ranks test). However, by 9 weeks after the end of treatment, T max (1.28 ± 0.69 h, n = 22) had again increased, and no differences were apparent between values before and after smoking cessation (Fig. 2) . As with T max , T 1/2 also showed a decrease from 1.66 ± 0.50 h to 1.53 ± 0.43 h by 1 week after the end of treatment. However, this change was not significant (n = 22, P = 0.058, Wilcoxon signed-ranks test). By 9 weeks after the end of treatment, T 1/2 (1.89 ± 0.53 h, n = 22) had again increased, and no differences were apparent between values before and after cessation of smoking (Fig. 3) .
β, not but κ, temporarily decreased after smoking cessation
At 1 week after the end of the treatment, parameter β decreased significantly from 2.46 ± 0.40 to 2.16 ± 0.58 (n = 22, P = 0.022, using the Wilcoxon signed-rank test). The decrease in β suggests that gastric emptying in the initial phase accelerates after smoking cessation. However, by 9 weeks after the end of the treatment, β (2.21 ± 0.40 , n = 22) again increased, and there were no differences were seen between the values before and after smoking cessation (Fig. 4) . Parameter κ showed no differences between before cessation (0.90 ± 0.21, n = 22) and 1 week (0.88 ± 0.22, n = 22) or 9 weeks (0.85 ± 0.28, n = 22) after the end of treatment (Fig. 5) .
DISCUSSION
The present study offers the first prospective examination of the effects of smoking cessation on gastric emptying in smokers. One week after the end of treatment, the rate of gastric emptying of liquid was significantly accelerated, particularly in the initial phase, as Kadota et al. , Page 8 compared with before smoking cessation. To understand the mechanisms underlying smoking cessation-evoked acceleration of gastric emptying, we need to determine the effects of chronic exposure to tobacco on gastric emptying. However, few reports have examined the chronic effects of smoking on gastric emptying. Hanson et al. (12) reported that smokers display a shorter gastric emptying half-life than nonsmokers using scintigraphy. The present study found that T max was significantly longer in smokers than in nonsmokers.
Conflicting results from a previous report (12) may have been due to the smaller subject population (under one-third of that in the present study) or differences in patient characteristics (only middle-aged men in the previous report). Numerous studies (13, 14) have shown that chronic exposure to tobacco is associated with sympathetic over-activity, which can contribute to various cardiovascular diseases. Not only does an acute and prominent increase in heart rate occur after smoking, but also a persistent increase is seen throughout the day (13) . Heart rate variability is reportedly reduced among chronic smokers (15) . Sympathetic overactivity in smokers may inhibit gastric emptying. In contrast to sympathetic overactivity in chronic smokers, smoking cessation appears to reduce the sympathetic bias. A decrease in heart rate (16) and an increase in heart rate variability (15) have been reported. Although the mechanisms underlying smoking cessation-evoked acceleration in gastric emptying are uncertain, re-emergence of vagal activity may work as one possible key player.
A second explanation is based on nitric oxide (NO). Levels of exhaled NO are known to be decreased in smokers (17, 18) . Hogman et al. (19) demonstrated that endogenous production of NO in the airways was increased after smoking cessation and was restored to normal values after 4 weeks without smoking. Endogenous NO plays an important role as a nonadrenergic, noncholinergic inhibitory neurotransmitter in the GI tract (20) . The relaxation role of endogenous NO during gastric adaptation to a meal in the proximal stomach has been Kadota et al., Page 9 clearly established (21, 22) . NO is also known to cause relaxation of the pylorus (20) .
Relaxation of the pylorus following gastric distension plays an important role in regulation of gastric emptying. Previous studies have shown that NO synthase inhibitors delay gastric emptying of solids or liquids in rats (23) and dogs (24) (25) (26) . The increase in endogenous NO after smoking cessation may cause relaxation of the pylorus and accelerate gastric emptying.
Further studies assessing levels of mRNA expression in the pylorus after smoking cessation are thus warranted.
We did not simultaneously obtain 13 C acetate breath test data and gastric scintigraphy data in order to minimize radiation exposure in our subjects. The 13 C acetate breath test was developed as a nonradioactive alternative for measurement of gastric emptying, and has been confirmed to correrate well with gastric scintigraphy (11, 27) . It is known that gastric emptying is a complex process with different mechanisms of emptying for liquids and solids (28) . In the present study, we only evaluated gastric emptying of liquids using the Various studies (33) have found evidence that smoking cessation is associated with weight gain and have agreed that weight gain is greater at 1 -2 months following cessation.
Most studies (34) have shown that smoking cessation increases appetite (food intake), which is considered to be one of the causes of weight gain after cessation. In this study, we confirmed that smoking cessation increases body weight and appetite, particularly at 1 week Kadota et al., Page 10 after the end of treatment, when gastric emptying for liquids is accelerated. Bergmann et al. (8) and Horowitz et al. (9) found a positive correlation between gastric emptying and appetite.
The temporary acceleration of gastric emptying for liquids after smoking cessation demonstrated in the present study may be involved in the temporary increase in appetite and weight gain after smoking cessation. Further evaluation of the mechanisms underlying accelerated gastric emptying is essential to clarify how gastric emptying is involved in temporary weight gain after smoking cessation.
It has been reported that delayed gastric emptying is present in approximately 40% of FD patients (35) . Although the pathophysiology of FD remains unknown, delayed gastric emptying has been implicated. Sarnelli et al. (32) reported that dyspeptic patients showed delayed gastric emptying for liquids, which is associated postprandial fullness and severe early satiety. Smoking cessation should thus be recommended to FD patients who smoke, as the acceleration in gastric emptying and change in appetite after smoking cessation could resolve the delayed emptying associated with early satiety in FD patients. showed a decreasing tendency, from 1.66 ± 0.50 h to 1.53 ± 0.43 h. This difference was not significant (P = 0.058). By 9 weeks after the end of treatment, T 1/2 had increased to 1.89 ± 0.53 h, with no significant difference when compared to values before smoking cessation. 
